Comparative phenotypic assessment of cardiac pathology, physiology, and gene expression in C3H/HeJ, C57BL/6J, and B6C3F1/J mice

Toxicologic Pathology

Volumn 38, Issue 6, 2010, Pages 923-942

  Auerbach, Scott S ^a   Thomas, Reuben ^a   Shah, Ruchir ^b   Hong Xu, ^a   Vallant, Molly K ^a   Nyska, Abraham ^a   Dunnick, June K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SRA International   (United States)

Author keywords

cardiomyopathy; electrophysiology; genetic susceptibly; genomics; heart

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B6C3F1 J MOUSE; C3H MOUSE; C57BL 6 MOUSE; CARDIOMYOPATHY; CARDIOTOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; GENOMICS; HEART FUNCTION; HEART RATE; HISTOPATHOLOGY; HYPOXIA; MALE; MORPHOLOGICAL TRAIT; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RR INTERVAL; STRAIN DIFFERENCE; STRESS;

ANIMALS; CARDIOMYOPATHIES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HEART RATE; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICROARRAY ANALYSIS; PHENOTYPE; RNA, MESSENGER; SPECIES SPECIFICITY;

MURINAE; MUS;

EID: 78649964341     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310382864     Document Type: Article

References (71)

1. Aiba, T., and Tomaselli, G.F. (2010). Electrical remodeling in the failing heart. Curr Opin Cardiol 25, 29-36.
2. Akar, F.G., and Tomaselli, G.F. (2005). Ion channels as novel therapeutic targets in heart failure. Ann Med 37, 44-54.
3. Arad, M., Seidman, C.E., and Seidman, J.G. (2007). AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100, 474-88.
4. Athea, Y., Viollet, B., Mateo, P., Rousseau, D., Novotova, M., Garnier, A., Vaulont, S., Wilding, J.R., Grynberg, A., Veksler, V., Hoerter, J., and Ventura-Clapier, R. (2007). AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes 56, 786-94.
5. Bazett, J. (1920). An analysis of time relation of electrocardiograms. Heart 7, 353-67.
6. Berthonneche, C., Peter, B., Schupfer, F., Hayoz, P., Kutalik, Z., Abriel, H., Pedrazzini, T., Beckmann, J.S., Bergmann, S., and Maurer, F. (2009). Cardiovascular response to beta-adrenergic blockade or activation in 23 inbred mouse strains. PloS One 4, e 6610.
7. Bettahi, I., Marker, C.L., Roman, M.I., and Wickman, K. (2002). Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J Biol Chem 277, 48282-88.
8. Bhattacharjee, A., Joiner, W.J., Wu, M., Yang, Y., Sigworth, F.J., and Kaczmarek, L.K. (2003). Slick (Sl02.1), a rapidly gating sodium-activated potassium channel inhibited by ATP. J Neurosci 23, 11681-91.
9. Blair, E., Redwood, C., Ashrafian, H., Oliveira, M., Broxholme, J., Kerr, B., Salmon, A., Ostman-Smith, I., and Watkins, H. (2001). Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Human Mol Genet 10, 1215-20.
10. Boudina, S., and Abel, E.D. (2007). Diabetic cardiomyopathy revisited. Circulation 115, 3213-23.
11. Chan, S.S., Santos, J.H., Meyer, J.N., Mandavilli, B.S., Cook, D.L., Jr., McCash, C.L., Kissling, G.E., Nyska, A., Foley, J.F., van Houten, B., Copeland, W.C., Walker, V.E., Witt, K.L., and Bishop, J.B. (2007). Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. Environ Mol Mutagen 48, 190-200.
12. Cheng, H., and Force, T. (2010). Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ Res 106, 21-34.
13. Chien, K.R., and Olson, E.N. (2002). Converging pathways and principles in heart development and disease: CV@CSH. Cell 110, 153-62.
14. Dahl, P., Danzi, S., and Klein, I. (2008). Thyrotoxic cardiac disease. Curr Heart Fail Rep 5, 170-76.
15. Dunnick, J., Blackshear, P., Kissling, G.E., Cunnningham, M., Parker, J., and Nyska, A. (2006). Critical pathways in heart function: bis(2-chloroethoxy) methane-induced heart gene transcript change in F344 rats. Toxicol Pathol 34, 348-56.
16. Dunnick, J., Johnson, J., Horton, J., and Nyska, A. (2004). Bis(2-chloroethoxy)methane-induced mitochondrial and myofibrillar damage: short-term time-course study. Toxicol Sci 80, 243-52.
17. Dunnick, J.K., Kissling, G., Gerken, D.K., Vallant, M.A., and Nyska, A. (2007). Carditoxicity of Ma Huang/caffeine or ephedrine/caffeine in a rodent model system. Toxicol Pathol 35, 657-664.
18. Dunnick, J.K., Lieuallen, W., Moyer, C., Orzech, D., and Nyska, A. (2004). Cardiac damage in rodents after exposure to bis(2-chloroethoxy)methane. Toxicol Pathol 32, 309-317.
19. Dunnick, J.K., Thayer, K.A., and Travlos, G.S. (2007). Inclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies. Toxicol Sci 100, 29-35.
20. Eaton, G.J., Custer, R.P., Johnson, F.N., and Stabenow, K.T. (1978). Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences. The American journal of pathology 90, 173-86.
21. Foo, R.S., Mani, K., and Kitsis, R.N. (2005). Death begets failure in the heart. The Journal of clinical investigation 115, 565-71.
22. Fowler, S.J., Napolitano, C., and Priori, S.G. (2009). The genetics of cardiomyopathy: genotyping and genetic counseling. Current treatment options in cardiovascular medicine 11, 433-46.
23. Frijters, R., Heupers, B., van Beek, P., Bouwhuis, M., van Schaik, R., de Vlieg, J., Polman, J., and Alkema, W. (2008). CoPub: a literature-based keyword enrichment tool for microarray data analysis. Nucleic Acids Res 36, W406-10.
24. Galindo, C.L., Skinner, M.A., Errami, M., Olson, L.D., Watson, D.A., Li, J., McCormick, J.F., McIver, L.J., Kumar, N.M., Pham, T.Q., and Garner, H.R. (2009). Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC physiology 9, 23.
25. Gollob, M.H., Green, M.S., Tang, A.S., Gollob, T., Karibe, A., Ali Hassan, A.S., Ahmad, F., Lozado, R., Shah, G., Fananapazir, L., Bachinski, L.L., and Roberts, R. (2001). Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. The New England journal of medicine 344, 1823-31.
26. Institute of Laboratory Animal Resources (1996). Guide for the care and use of laboratory animals. National Academy Press, Washington, D. C.
27. Ivandic, B.T., Qiao, J.H., Machleder, D., Liao, F., Drake, T.A., and Lusis, A.J. (1996). A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice Proc Natl Acad Sci U S A. 1996 May 28; 93 (11). 5483-8.
28. James, P.F., Grupp, I.L., Grupp, G., Woo, A.L., Askew, G.R., Croyle, M.L., Walsh, R.A., and Lingrel, J.B. (1999). Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Molecular cell 3, 555-63.
29. Jessup, M., and Brozena, S. (2003). Heart failure. The New England journal of medicine 348, 2007-18.
30. Jokinen, M.P., Lieuallen, W.G., Johnson, C.L., Dunnick, J., and Nyska, A. (2005). Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems: the National Toxicology Program experience. Cardiovascular toxicology 5, 227-44.
31. Jupiter, D.C., and VanBuren, V. (2008). A visual data mining tool that facilitates reconstruction of transcription regulatory networks. PloS one 3, e 1717.
32. Kamburov, A., Wierling, C., Lehrach, H., and Herwig, R. (2009). ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res 37, D623-8.
33. Kane, G.C., Liu, X.K., Yamada, S., Olson, T.M., and Terzic, A. (2005). Cardiac KATP channels in health and disease. Journal of molecular and cellular cardiology 38, 937-43.
34. Kathiresan, S., Voight, B.F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P.M., Anand, S., Engert, J.C., Samani, N.J., Schunkert, H., Erdmann, J., Reilly, M.P., Rader, D.J., Morgan, T., Spertus, J.A., Stoll, M., Girelli, D., McKeown, P.P., Patterson, C.C., Siscovick, D.S., O'Donnell, C.J., Elosua, R., Peltonen, L., Salomaa, V., Schwartz, S.M., Melander, O., Altshuler, D., Ardissino, D., Merlini, P.A., Berzuini, C., Bernardinelli, L., Peyvandi, F., Tubaro, M., Celli, P., Ferrario, M., Fetiveau, R., Marziliano, N., Casari, G., Galli, M., Ribichini, F., Rossi, M., Bernardi, F., Zonzin, P., Piazza, A., Mannucci, P.M., Schwartz, S.M., Siscovick, D.S., Yee, J., Friedlander, Y., Elosua, R., Marrugat, J., Lucas, G., Subirana, I., Sala, J., Ramos, R., Kathiresan, S., Meigs, J.B., Williams, G., Nathan, D.M., MacRae, C.A., O'Donnell, C.J., Salomaa, V., Havulinna, A.S., Peltonen, L., Melander, O., Berglund, G., Voight, B.F., Kathiresan, S., Hirschhorn, J.N., Asselta, R., Duga, S., Spreafico, M., Musunuru, K., Daly, M.J., Purcell, S., Voight, B.F., Purcell, S., Nemesh, J., Korn, J.M., McCarroll, S.A., Schwartz, S.M., Yee, J., Kathiresan, S., Lucas, G., Subirana, I., Elosua, R., Surti, A., Guiducci, C., Gianniny, L., Mirel, D., Parkin, M., Burtt, N., Gabriel, S.B., Samani, N.J., Thompson, J.R., Braund, P.S., Wright, B.J., Balmforth, A.J., Ball, S.G., Hall, A.S., Schunkert, H., Erdmann, J., Linsel-Nitschke, P., Lieb, W., Ziegler, A., Konig, I., Hengstenberg, C., Fischer, M., Stark, K., Grosshennig, A., Preuss, M., Wichmann, H.E., Schreiber, S., Schunkert, H., Samani, N.J., Erdmann, J., Ouwehand, W., Hengstenberg, C., Deloukas, P., Scholz, M., Cambien, F., Reilly, M.P., Li, M., Chen, Z., Wilensky, R., Matthai, W., Qasim, A., Hakonarson, H.H., Devaney, J., Burnett, M.S., Pichard, A.D., Kent, K.M., Satler, L., Lindsay, J.M., Waksman, R., Epstein, S.E., Rader, D.J., Scheffold, T., Berger, K., Stoll, M., Huge, A., Girelli, D., Martinelli, N., Olivieri, O., Corrocher, R., Morgan, T., Spertus, J.A., McKeown, P., Patterson, C.C., Schunkert, H., Erdmann, E., Linsel-Nitschke, P., Lieb, W., Ziegler, A., Konig, I.R., Hengstenberg, C., Fischer, M., Stark, K., Grosshennig, A., Preuss, M., Wichmann, H.E., Schreiber, S., Holm, H., Thorleifsson, G., Thorsteinsdottir, U., Stefansson, K., Engert, J.C., Do, R., Xie, C., Anand, S., Kathiresan, S., Ardissino, D., Mannucci, P.M., Siscovick, D., O'Donnell, C.J., Samani, N.J., Melander, O., Elosua, R., Peltonen, L., Salomaa, V., Schwartz, S.M., and Altshuler, D. (2009). Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature genetics 41, 334-41.
35. Le Bouter, S., Demolombe, S., Chambellan, A., Bellocq, C., Aimond, F., Toumaniantz, G., Lande, G., Siavoshian, S., Baro, I., Pond, A.L., Nerbonne, J.M., Leger, J.J., Escande, D., and Charpentier, F. (2003). Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology. Circulation research 92, 234-42.
36. Makita, N., Horie, M., Nakamura, T., Ai, T., Sasaki, K., Yokoi, H., Sakurai, M., Sakuma, I., Otani, H., Sawa, H., and Kitabatake, A. (2002). Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 106, 1269-74.
37. Maronpot, R.R., Boorman, G.A., and Gaul, B.W. (1999). Pathology of the mouse: reference and atlas. Cache River Press, Vienna, IL.
38. McKee, E.E., Bentley, A.T., Hatch, M., Gingerich, J., and Susan-Resiga, D. (2004). Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovascular toxicology 4, 155-67.
39. Medeiros-Domingo, A., Kaku, T., Tester, D.J., Iturralde-Torres, P., Itty, A., Ye, B., Valdivia, C., Ueda, K., Canizales-Quinteros, S., Tusie-Luna, M.T., Makielski, J.C., and Ackerman, M.J. (2007). SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 116, 134-42.
40. Meng, H., Vera, I., Che, N., Wang, X., Wang, S.S., Ingram-Drake, L., Schadt, E.E., Drake, T.A., and Lusis, A.J. (2007). Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci U S A. 2007 Mar 13; 104 (11). 4530-5. Epub 2007 Mar 6.
41. Miyoshi, T., Tian, J., Matsumoto, A.H., and Shi, W. (2006). Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis 189, 99-105.
42. Morita, H., Seidman, J., and Seidman, C.E. (2005). Genetic causes of human heart failure. The Journal of clinical investigation 115, 518-26.
43. National Center for Health Statistics (2005 a). Mortality data from the national vital statistics system. http://www.cdc.gov/nchs/deaths.htm
44. National Center for Health Statistics (2005 b). Heart Disease Fact Sheet. http://www.cdc.gov/cvh/library/fs-heart-disease.htm
45. Neubauer, S. (2007). The failing heart-an engine out of fuel. The New England journal of medicine 356, 1140-51.
46. Nyska, A., Murphy, E., Foley, J.F., Collins, B.J., Petranka, J., Howden, R., Hanlon, P., and Dunnick, J.K. (2005 a). Acut hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Tox Sci 83, 388-396.
47. Nyska, A., Murphy, E., Foley, J.F., Collins, B.J., Petranka, J., Howden, R., Hanlon, P., and Dunnick, J.K. (2005 b). Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicol Sci 83, 388-96.
48. Pritchard, J.B., French, J.E., Davis, B.J., and Haseman, J.K. (2003). The role of transgenic mouse models in carcinogen identification. Environmental health perspectives 111, 444-54.
49. Rajabi, M., Kassiotis, C., Razeghi, P., and Taegtmeyer, H. (2007). Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12, 331-43.
50. Rao, G.N., and Crockett, P.W. (2003). Effect of diet and housing on growth, body weight, survival and tumor incidences of B6C3F1 mice in chronic studies. Toxicol Pathol 31, 243-50.
51. Rohini, A., Agrawal, N., Koyani, C.N., and Singh, R. (2009). Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res.
52. Ruben, Z., Arceo, R.J., Bishop, S.P., Elwell, M.R., Kerns, W.D., Mesfin, G.M., Sandusky, G.E., and Van Vleet, J.F. (2000). Non-proliferative lesions of the heart and vasculature in rats. STP/ARP/ AFIP, Washington DC.
53. Samani, N.J., Erdmann, J., Hall, A.S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R.J., Meitinger, T., Braund, P., Wichmann, H.E., Barrett, J.H., Konig, I.R., Stevens, S.E., Szymczak, S., Tregouet, D.A., Iles, M.M., Pahlke, F., Pollard, H., Lieb, W., Cambien, F., Fischer, M., Ouwehand, W., Blankenberg, S., Balmforth, A.J., Baessler, A., Ball, S.G., Strom, T.M., Braenne, I., Gieger, C., Deloukas, P., Tobin, M.D., Ziegler, A., Thompson, J.R., and Schunkert, H. (2007). Genomewide association analysis of coronary artery disease. The New England journal of medicine 357, 443-53.
54. Shi, W., Wang, N.J., Shih, D.M., Sun, V.Z., Wang, X., and Lusis, A.J. (2000). Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circulation research 86, 1078-84.
55. Shioi, T., McMullen, J.R., Tarnavski, O., Converso, K., Sherwood, M.C., Manning, W.J., and Izumo, S. (2003). Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107, 1664-70.
56. Taha, M., and Lopaschuk, G.D. (2007). Alterations in energy metabolism in cardiomyopathies. Annals of medicine 39, 594-607.
57. Viollet, B., Andreelli, F., Jorgensen, S.B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., Gomas, E., Nicolas, G., Wojtaszewski, J.F., Kahn, A., Carling, D., Schuit, F.C., Birnbaum, M.J., Richter, E.A., Burcelin, R., and Vaulont, S. (2003). The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. The Journal of clinical investigation 111, 91-8.
58. Viollet, B., Athea, Y., Mounier, R., Guigas, B., Zarrinpashneh, E., Horman, S., Lantier, L., Hebrard, S., Devin-Leclerc, J., Beauloye, C., Foretz, M., Andreelli, F., Ventura-Clapier, R., and Bertrand, L. (2009). AMPK: Lessons from transgenic and knockout animals. Front Biosci 14, 19-44.
59. Walker, D.M., Poirier, M.C., Campen, M.J., Cook, D.L., Jr., Divi, R.L., Nagashima, K., Lund, A.K., Cossey, P.Y., Hahn, F.F., and Walker, V.E. (2004). Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine. Cardiovascular toxicology 4, 133-53.
60. Wallenborn, J.G., Schladweiler, M.C., Nyska, A., Johnson, J.A., Thomas, R., Jaskot, R.H., Richards, J.H., Ledbetter, A.D., and Kodavanti, U.P. (2007). Cardiopulmonary responses of Wistar Kyoto, spontaneously hypertensive, and stroke-prone spontaneously hypertensive rats to particulate matter (PM) exposure. Journal of toxicology and environmental health 70, 1912-22.
61. Wang, S.S., Schadt, E.E., Wang, H., Wang, X., Ingram-Drake, L., Shi, W., Drake, T.A., and Lusis, A.J. (2007). Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circulation research 101, e11-30.
62. Wang, S.S., Shi, W., Wang, X., Velky, L., Greenlee, S., Wang, M.T., Drake, T.A., and Lusis, A.J. (2007). Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice. Arteriosclerosis, thrombosis, and vascular biology 27, 2671-6.
63. Watanabe, H., Koopmann, T.T., Le Scouarnec, S., Yang, T., Ingram, C.R., Schott, J.J., Demolombe, S., Probst, V., Anselme, F., Escande, D., Wiesfeld, A.C., Pfeufer, A., Kaab, S., Wichmann, H.E., Hasdemir, C., Aizawa, Y., Wilde, A.A., Roden, D.M., and Bezzina, C.R. (2008). Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. The Journal of clinical investigation 118, 2260-8.
64. Wheeler, F.C., Tang, H., Marks, O.A., Hadnott, T.N., Chu, P.L., Mao, L., Rockman, H.A., and Marchuk, D.A. (2009). Tnni3k modifies disease progression in murine models of cardiomyopathy. PLoS genetics 5, e 1000647.
65. Wilson, C.L., and Miller, C.J. (2005). Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics (Oxford, England) 21, 3683-5.
66. Wu, C.C., Huang, H.C., Juan, H.F., and Chen, S.T. (2004). GeneNetwork: an interactive tool for reconstruction of genetic networks using microarray data. Bioinformatics (Oxford, England) 20, 3691-3.
67. Yang, X., Schadt, E.E., Wang, S., Wang, H., Arnold, A.P., Ingram-Drake, L., Drake, T.A., and Lusis, A.J. (2006). Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome research 16, 995-1004.
68. Yano, M., Ikeda, Y., and Matsuzaki, M. (2005). Altered intracellular Ca2+ handling in heart failure. The Journal of clinical investigation 115, 556-64.
69. Yuan, Z., Miyoshi, T., Bao, Y., Sheehan, J.P., Matsumoto, A.H., and Shi, W. (2009). Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility. American journal of physiology 296, H1336-43.
70. Zarrinpashneh, E., Carjaval, K., Beauloye, C., Ginion, A., Mateo, P., Pouleur, A.C., Horman, S., Vaulont, S., Hoerter, J., Viollet, B., Hue, L., Vanoverschelde, J.L., and Bertrand, L. (2006). Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. American journal of physiology 291, H2875-83.
71. Zhang, P., Hu, X., Xu, X., Fassett, J., Zhu, G., Viollet, B., Xu, W., Wiczer, B., Bernlohr, D.A., Bache, R.J., and Chen, Y. (2008). AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension 52, 918-24.